Vibha Ravi - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Vibha Ravi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Vibha Ravi

Vibha Ravi

Verified

Senior Editor, Citeline

Mumbai

Final Covers

Politics

Doesn’t Cover

fitness

Journalist Type

Seniority Positions

Medium Formats

Content

Total articles 394

  • Pipeline To Product - What Is Driving Cell And Gene Therapy Progress In India?

    By Vibha Ravi Verified

    Apr. 09, 2025

  • What Is Fuelling Cell And Gene Therapies In India?

    By Vibha Ravi Verified

    Apr. 07, 2025

  • Pipeline To Product - What Is Driving Cell And Gene Therapy Progress In India?

    By Vibha Ravi Verified

    Apr. 09, 2025

As seen in

Company Info

Citeline

Citeline, part of Norstella, is a global leader in pharmaceutical and medtech business intelligence solutions. The company is dedicated to connecting treatments with patients by providing data-driven insights across clinical, commercial, and regulatory areas. Its mission is to ensure timely access to treatments through evidence-based decision-making tools. Citeline offers a range of specialized solutions, including real-time R&D intelligence, regulatory compliance support, and in-depth analysis of industry trends. Their clinical solutions provide global clinical trial data and tools for protocol design and enrollment benchmarking. Additionally, Citeline enhances patient engagement and recruitment through awareness campaigns and educational resources. The company serves over 180,000 users worldwide, including pharmaceutical companies, biotech firms, and clinical research organizations, supporting professionals throughout the drug development lifecycle. With a global team of analysts and consultants, Citeline curates valuable insights on key diseases and market forecasts, emphasizing a patient-centric approach to address challenges in clinical trials and market competition.

, ,

'+1 646-957-8919

Founded: 1997